Israel Englander Nuvectis Pharma, Inc. Transaction History
Millennium Management LLC
- $175 Billion
- Q1 2025
A detailed history of Israel Englander (Millennium Management LLC) transactions in Nuvectis Pharma, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 121,101 shares of NVCT stock, worth $827,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
121,101
Previous 29,698
307.77%
Holding current value
$827,119
Previous $161,000
634.78%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding NVCT
# of Institutions
50Shares Held
3.2MCall Options Held
116KPut Options Held
87.6K-
Vanguard Group Inc Valley Forge, PA667KShares$4.55 Million0.0% of portfolio
-
Ronit Capital LLP563KShares$3.84 Million5.37% of portfolio
-
Baldwin Brothers LLC350KShares$2.39 Million0.19% of portfolio
-
Geode Capital Management, LLC Boston, MA285KShares$1.95 Million0.0% of portfolio
-
Iridian Asset Management LLC254KShares$1.73 Million0.82% of portfolio
About Nuvectis Pharma, Inc.
- Ticker NVCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,642,500
- Market Cap $100M
- Description
- Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900, a small molecule drug candidate to inhibit the Proto-oncogene c-Src...